|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4178 | |
| A61K 31/445 | |||
| A61K 31/473 | |||
| A61K 31/27 | |||
| A61K 31/55 | |||
| A61K 31/4748 | |||
| A61K 9/48 | |||
| A61K 9/20 | |||
| A61P 25/28 |
| (11) | Number of the document | 2478099 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10817543.1 |
| Date of filing the European patent application | 2010-09-13 | |
| (97) | Date of publication of the European application | 2012-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/002475 |
| Date | 2010-09-13 |
| (87) | Number | WO 2011/034568 |
| Date | 2011-03-24 |
| (30) | Number | Date | Country code |
| 272382 P | 2009-09-18 | US |
| (72) |
CHASE, Thomas N., US
CLARENCE-SMITH, Kathleen E., US
|
| (73) |
Chase Pharmaceuticals Corporation,
5 Giralda Farms,, Madison, New Jersey 07940,
US
|
| (54) | COMBINATION FOR TREATING ALZHEIMER-TYPE DEMENTIA |
| COMBINATION FOR TREATING ALZHEIMER-TYPE DEMENTIA |